OpenFilings

AEON Biopharma, Inc.

Form10-K/A

Report Period2023-12-31

Date Filed2024-05-14

Time Filed09:05:41

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K/A
EX-10.11
EX-23.1
EX-23.2
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-97
Filing on SEC Edgar